Bank of Montreal’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History

Bank of Montreal’s Portfolio ZYNE Stock Details ZYNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,200	Closed	-$31K	–	4875
2019 Q4	$31K	Hold	5,200	–	–	﹤0.01%	4073
2019 Q3	$39K	Hold	5,200	–	–	﹤0.01%	3746
2019 Q2	$70K	Buy	+5,200	New	+$60K	﹤0.01%	3533
2019 Q1	–	Sell	-1,200	Closed	-$4K	–	4867
2018 Q4	$4K	Hold	1,200	–	–	﹤0.01%	4195
2018 Q3	$10K	Sell	1,200 -36,300	-97%	-$279K	﹤0.01%	3937
2018 Q2	$365K	Buy	+37,500	New	+$384K	﹤0.01%	2480
2017 Q4	–	Sell	-42,500	Closed	-$355K	–	4372
2017 Q3	$355K	Buy	+42,500	New	+$449K	﹤0.01%	2424

Other funds holding ZYNE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

PCM

Prentice Capital Management Greenwich, Connecticut $45.7M AUM 2.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Bank of Montreal's ZYNE Position: Q3 2020 in Review

Bank of Montreal sold out of Zynerba Pharmaceuticals, Inc (ZYNE) in Q3 2020, closing a stake of 967 shares — an estimated $3K sold.

Bank of Montreal first reported a position in ZYNE in Q2 2017 and held it in 11 quarters. The position peaked at $365K in Q2 2018. 66 funds tracked by Wall St. Rank hold ZYNE as of Q3 2020.

Bank of Montreal reported no remaining Zynerba Pharmaceuticals, Inc position as of Q3 2020 after selling out during the quarter.
Bank of Montreal sold 967 Zynerba Pharmaceuticals, Inc shares in Q3 2020, an estimated $3K.
Bank of Montreal first reported a position in Zynerba Pharmaceuticals, Inc in Q2 2017 and held it in 11 quarters.
Bank of Montreal's Zynerba Pharmaceuticals, Inc position peaked at $365K in Q2 2018.
66 funds tracked by Wall St. Rank held Zynerba Pharmaceuticals, Inc as of Q3 2020.

Based on Bank of Montreal's 13F filing for Q3 2020, filed 12 Nov 2020.